Comparison of human and mouse tissues with focus on genes with no 1-to-1 homology

Jieun Jeong, Manolis KellisbioRxiv 2021 · DOI

Abstract: We assembled a panel of 28 tissue pairs of human and mouse with RNA-Seq data on gene expression. We focused on genes with no 1-to-1 homology, because they pose special challenges. In this way, we identified expression patterns that identify and explain differences between the two species and suggest target genes for therapeutic applications. Here we mention three examples. One pattern is observed by defining the aggregate expression of immunoglobulin genes (which have no homology) as a measure of different levels of an immune response. In Lung, we used this statistic to find genes that have significantly higher expression in low/moderate response, and thus they may be therapy targets: increasing their expression or mimicking their function with medications may help in recovery from inflammation in the lungs. Some of the observed associations are common to human and mouse; other associations involve genes involved in cell-to-cell signaling or in regeneration but were not known to be important in Lung. Second pattern is that in the Small Intestine, mouse expresses much less antimicrobial defensins, while it has much higher expression of enzymes that are found to improve adaptive immune response. Such enzymes may be tested if they improve probiotic supplements that help in gut inflammation and other diseases. Another pattern involves a many-to-many homology group of defensins that did not have a described function. In human tissues, expression of its genes was found only in a study of a disease of hair covered skin, but several of its genes are highly expressed in two tissues of our panel: mouse Skin and to a lesser degree mouse Vagina. This suggests that those genes or their homologs in other species may provide non-antibiotic medications for hair covered skin and other tissues with microbiome that includes fungi.

Introduction

Mice are the primary model organisms in biomedical research, yet the translation of mouse-based findings to human clinical applications remains a significant challenge. A major obstacle is the presence of genomic "dark matter"—genes that do not possess a clear 1-to-1 orthologous relationship between species. While most comparative genomics studies focus on these "safe" 1-to-1 orthologs to simplify analysis, the genes that diverge are often the most biologically significant. These rapidly evolving genes frequently drive unique species adaptations, particularly in systems under intense evolutionary pressure, such as the immune system and the digestive tract.

This study addresses this gap by analyzing a transcriptomic atlas of 28 matching tissue pairs from humans and mice. By focusing on "complex homology" groups (one-to-many or many-to-many) and genes with no known homology, we identify expression patterns that explain species differences and suggest novel therapeutic targets.

Methodology

The researchers utilized human data from the GTEx (Genotype-Tissue Expression) project and mouse data from a combination of sources, including GEO, ENCODE, and the Tabula Muris Senis project. To navigate the complexities of non-orthologous genes, the study employed several innovative techniques:

  1. Bipartite Graph Homology: Homology groups were defined using a bipartite graph where edges represent homologous pairs from major databases, categorizing genes into 1-to-1, complex, or no homology.
  2. Aggregate Expression Metrics: To compare functionally similar but non-homologous gene families, the authors used aggregate statistics such as total defensins ($\sum$Def), total immunoglobulins ($\sum$Ig), and total T-cell receptors ($\sum$TR).
  3. Contamination Filtering: A novel method was developed to identify and exclude "leaky" data, where high-expression tissues (e.g., pancreas) contaminated adjacent tissue samples in public datasets.

Results and Discussion

The Landscape of Gene Homology

The distribution of gene expression across homology categories varies significantly by tissue. As shown in Figure 1, while 1-to-1 homology accounts for the majority of expression in most tissues, certain organs exhibit high levels of complex or no homology expression.

Proportion of reads mapped to different homology categories across 28 human and mouse tissue pairs.

The pancreas, for instance, shows the highest proportion of reads mapped to genes with complex homology, driven by rapidly duplicating digestive proteases and amylases. Conversely, salivary glands exhibit a high presence of protein-coding genes with no homology, primarily due to species-specific mucins.

Salivary Gland Divergence and the "Licking Wounds" Signature

The salivary glands represent a point of extreme divergence. Mouse submandibular glands express unique mucins ($Mucl1$, $Mucl2$) and extremely high levels of growth factors like $Ngf$ and $Egf$ that are not found at comparable levels in humans. This molecular profile likely supports the wound-healing properties associated with mouse saliva (the "licking wounds" signature).

Comparison of gene expression levels in salivary glands, highlighting species-specific differences in growth factors and mucins.

As detailed in Figure 3, genes like $BPIFB2$ and $EGF$ show massive expression differences between mouse and human submandibular tissues, emphasizing the functional specialization of these organs.

Immune Signaling and Gut Health

The study also utilized total immunoglobulin expression ($\sum$Ig) as a biological sensor for the "immune state" of a tissue. In the lung, this allowed for the identification of genes like $ESM1$ and $IL1RL1$ that are markers of a healthy, low-inflammation state, potentially serving as targets for recovery-promoting therapies.

In the digestive tract, a significant "IAP deficiency gap" was identified. Mice express Intestinal Alkaline Phosphatases (IAPs) at levels nearly 100 times higher than humans. Given that IAPs neutralize bacterial toxins, this suggests that human gut health might be improved through IAP-based probiotic supplementation.

Conclusion

By looking beyond 1-to-1 orthologs, this research highlights how species-specific genes define the unique physiological landscapes of humans and mice. These findings not only improve our understanding of model organism limitations but also open new avenues for therapeutic intervention in lung inflammation, gut health, and antifungal treatments. Future work utilizing single-cell data will further refine these "complex homology" maps to identify the specific cell types driving these evolutionary divergences.

Summary updated

Abstract

Abstract We assembled a panel of 28 tissue pairs of human and mouse with RNA-Seq data on gene expression. We focused on genes with no 1-to-1 homology, because they pose special challenges. In this way, we identified expression patterns that identify and explain differences between the two species and suggest target genes for therapeutic applications. Here we mention three examples. One pattern is observed by defining the aggregate expression of immunoglobulin genes (which have no homology) as a measure of different levels of an immune response. In Lung, we used this statistic to find genes that have significantly higher expression in low/moderate response, and thus they may be therapy targets: increasing their expression or mimicking their function with medications may help in recovery from inflammation in the lungs. Some of the observed associations are common to human and mouse; other associations involve genes involved in cell-to-cell signaling or in regeneration but were not known to be important in Lung. Second pattern is that in the Small Intestine, mouse expresses much less antimicrobial defensins, while it has much higher expression of enzymes that are found to improve adaptive immune response. Such enzymes may be tested if they improve probiotic supplements that help in gut inflammation and other diseases. Another pattern involves a many-to-many homology group of defensins that did not have a described function. In human tissues, expression of its genes was found only in a study of a disease of hair covered skin, but several of its genes are highly expressed in two tissues of our panel: mouse Skin and to a lesser degree mouse Vagina. This suggests that those genes or their homologs in other species may provide non-antibiotic medications for hair covered skin and other tissues with microbiome that includes fungi.
BibTeX
@misc{jeong2021comparison,
  author = {Jieun Jeong and Manolis Kellis},
  title = {{Comparison of human and mouse tissues with focus on genes with no 1-to-1 homology}},
  year = {2021},
  doi = {10.1101/2021.05.22.445250},
  howpublished = {bioRxiv},
}
Figure